ID   SMF No.9
AC   CVCL_0H74
DR   Wikidata; Q54954954
RX   PubMed=24859480;
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Homozygous (PubMed=24859480).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27701; Secondary myelofibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0H70 ! SMF No.5
OI   CVCL_0H71 ! SMF No.6
OI   CVCL_0H72 ! SMF No.7
OI   CVCL_0H73 ! SMF No.8
OI   CVCL_0H75 ! SMF No.12
OI   CVCL_0H76 ! SMF No.15
OI   CVCL_0H77 ! SMF No.16
OI   CVCL_0H78 ! SMF No.17
OI   CVCL_0H79 ! SMF No.20
OI   CVCL_0H80 ! SMF No.21
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 9
//
RX   PubMed=24859480; DOI=10.1016/j.exphem.2014.03.010;
RA   Hosoi M., Kumano K., Taoka K., Arai S., Kataoka K., Ueda K.,
RA   Kamikubo Y., Takayama N., Otsu M., Eto K., Nakauchi H., Kurokawa M.;
RT   "Generation of induced pluripotent stem cells derived from primary and
RT   secondary myelofibrosis patient samples.";
RL   Exp. Hematol. 42:816-825(2014).
//